453 related articles for article (PubMed ID: 31736941)
1. El Tor Biotype
Mamantopoulos M; Frising UC; Asaoka T; van Loo G; Lamkanfi M; Wullaert A
Front Immunol; 2019; 10():2463. PubMed ID: 31736941
[No Abstract] [Full Text] [Related]
2. Mechanisms of inflammasome activation by Vibrio cholerae secreted toxins vary with strain biotype.
Queen J; Agarwal S; Dolores JS; Stehlik C; Satchell KJ
Infect Immun; 2015 Jun; 83(6):2496-506. PubMed ID: 25847959
[TBL] [Abstract][Full Text] [Related]
3. Novel Cholera Toxin Variant and ToxT Regulon in Environmental
Neogi SB; Chowdhury N; Awasthi SP; Asakura M; Okuno K; Mahmud ZH; Islam MS; Hinenoya A; Nair GB; Yamasaki S
Appl Environ Microbiol; 2019 Feb; 85(3):. PubMed ID: 30446560
[TBL] [Abstract][Full Text] [Related]
4. New variants of Vibrio cholerae O1 biotype El Tor with attributes of the classical biotype from hospitalized patients with acute diarrhea in Bangladesh.
Nair GB; Faruque SM; Bhuiyan NA; Kamruzzaman M; Siddique AK; Sack DA
J Clin Microbiol; 2002 Sep; 40(9):3296-9. PubMed ID: 12202569
[TBL] [Abstract][Full Text] [Related]
5. Hemolysin and the multifunctional autoprocessing RTX toxin are virulence factors during intestinal infection of mice with Vibrio cholerae El Tor O1 strains.
Olivier V; Haines GK; Tan Y; Satchell KJ
Infect Immun; 2007 Oct; 75(10):5035-42. PubMed ID: 17698573
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional Silencing by TsrA in the Evolution of Pathogenic Vibrio cholerae Biotypes.
Caro F; Caro JA; Place NM; Mekalanos JJ
mBio; 2020 Nov; 11(6):. PubMed ID: 33234688
[No Abstract] [Full Text] [Related]
7. Characterization of Vibrio cholerae O1 isolates responsible for cholera outbreaks in Kenya between 1975 and 2017.
Bundi M; Shah MM; Odoyo E; Kathiiko C; Wandera E; Miring'u G; Guyo S; Langat D; Morita K; Ichinose Y
Microbiol Immunol; 2019 Sep; 63(9):350-358. PubMed ID: 31407393
[TBL] [Abstract][Full Text] [Related]
8. Emergence and genetic diversity of El Tor Vibrio cholerae O1 that possess classical biotype ctxB among travel-associated cases of cholera in Japan.
Morita M; Ohnishi M; Arakawa E; Yamamoto S; Nair GB; Matsushita S; Yokoyama K; Kai A; Seto K; Watanabe H; Izumiya H
J Med Microbiol; 2010 Jun; 59(Pt 6):708-712. PubMed ID: 20223896
[TBL] [Abstract][Full Text] [Related]
9. Cholera toxin B induces interleukin-1β production from resident peritoneal macrophages through the pyrin inflammasome as well as the NLRP3 inflammasome.
Orimo T; Sasaki I; Hemmi H; Ozasa T; Fukuda-Ohta Y; Ohta T; Morinaka M; Kitauchi M; Yamaguchi T; Sato Y; Tanaka T; Hoshino K; Katayama KI; Fukuda S; Miyake K; Yamamoto M; Satoh T; Furukawa K; Kuroda E; Ishii KJ; Takeda K; Kaisho T
Int Immunol; 2019 Sep; 31(10):657-668. PubMed ID: 30689886
[TBL] [Abstract][Full Text] [Related]
10. Cholera Toxin Production in
Baek Y; Lee D; Lee J; Yoon Y; Nair GB; Kim DW; Kim EJ
Front Microbiol; 2020; 11():825. PubMed ID: 32431681
[No Abstract] [Full Text] [Related]
11. Cholera outbreaks in the El Tor biotype era and the impact of the new El Tor variants.
Mukhopadhyay AK; Takeda Y; Balakrish Nair G
Curr Top Microbiol Immunol; 2014; 379():17-47. PubMed ID: 24710767
[TBL] [Abstract][Full Text] [Related]
12. Molecular insights into the evolutionary pathway of Vibrio cholerae O1 atypical El Tor variants.
Kim EJ; Lee D; Moon SH; Lee CH; Kim SJ; Lee JH; Kim JO; Song M; Das B; Clemens JD; Pape JW; Nair GB; Kim DW
PLoS Pathog; 2014 Sep; 10(9):e1004384. PubMed ID: 25233006
[TBL] [Abstract][Full Text] [Related]
13. Emergence of Vibrio cholerae O1 classical biotype in 2012 in Iran.
Bakhshi B; Boustanshenas M; Mahmoudi-aznaveh A
Lett Appl Microbiol; 2014 Feb; 58(2):145-9. PubMed ID: 24117836
[TBL] [Abstract][Full Text] [Related]
14. Cholera outbreaks in the classical biotype era.
Siddique AK; Cash R
Curr Top Microbiol Immunol; 2014; 379():1-16. PubMed ID: 24368696
[TBL] [Abstract][Full Text] [Related]
15. Shiga Toxin/Lipopolysaccharide Activates Caspase-4 and Gasdermin D to Trigger Mitochondrial Reactive Oxygen Species Upstream of the NLRP3 Inflammasome.
Platnich JM; Chung H; Lau A; Sandall CF; Bondzi-Simpson A; Chen HM; Komada T; Trotman-Grant AC; Brandelli JR; Chun J; Beck PL; Philpott DJ; Girardin SE; Ho M; Johnson RP; MacDonald JA; Armstrong GD; Muruve DA
Cell Rep; 2018 Nov; 25(6):1525-1536.e7. PubMed ID: 30404007
[TBL] [Abstract][Full Text] [Related]
16. Variation in epitopes of the B subunit of El Tor and classical biotype Vibrio cholerae O1 cholera toxin.
Tamplin ML; Ahmed MK; Jalali R; Colwell RR
J Gen Microbiol; 1989 May; 135(5):1195-200. PubMed ID: 2482860
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Vibrio cholerae genome sequences reveals unique rtxA variants in environmental strains and an rtxA-null mutation in recent altered El Tor isolates.
Dolores J; Satchell KJ
mBio; 2013 Apr; 4(2):e00624. PubMed ID: 23592265
[TBL] [Abstract][Full Text] [Related]
18. Replication of
Kim EJ; Yu HJ; Lee JH; Kim JO; Han SH; Yun CH; Chun J; Nair GB; Kim DW
Proc Natl Acad Sci U S A; 2017 Feb; 114(9):2343-2348. PubMed ID: 28196886
[TBL] [Abstract][Full Text] [Related]
19. CVD110, an attenuated Vibrio cholerae O1 El Tor live oral vaccine strain.
Michalski J; Galen JE; Fasano A; Kaper JB
Infect Immun; 1993 Oct; 61(10):4462-8. PubMed ID: 8406837
[TBL] [Abstract][Full Text] [Related]
20. CTX prophages in Vibrio cholerae O1 strains.
Kim EJ; Lee D; Moon SH; Lee CH; Kim DW
J Microbiol Biotechnol; 2014 Jun; 24(6):725-31. PubMed ID: 24722374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
